Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region

Hepatocellular carcinoma (HCC) is a growing health concern projected to cross over a million cases worldwide by 2025. HCC presents a significant burden of disease in Middle East and North African (MENA) countries due to a high prevalence of risk factors such as hepatitis C and B infections and risin...

Full description

Saved in:
Bibliographic Details
Published in:Liver international 2023-10, Vol.43 (10), p.2062-2077
Main Authors: Waked, Imam, Alsammany, Sherif, Tirmazy, Sayed Hammad, Rasul, Kakil, Bani-Issa, Jafar, Abdel-Razek, Wael, Omar, Ashraf, Shafik, Amr, Eid, Salem, Abdelaal, Amr, Hosni, Ahmed, Esmat, Gamal
Format: Article
Language:English
Subjects:
Biomarkers
Fatty liver
Health services
Hepatitis C
Hepatocellular carcinoma
Liver
Liver cancer
Liver diseases
Patients
Risk factors
Standardization
Surveillance systems
System effectiveness
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hepatocellular carcinoma (HCC) is a growing health concern projected to cross over a million cases worldwide by 2025. HCC presents a significant burden of disease in Middle East and North African (MENA) countries due to a high prevalence of risk factors such as hepatitis C and B infections and rising incidence of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. In August 2022, an advisory meeting consisting of experts from 5 MENA countries was convened in an attempt to provide consensus recommendations on HCC screening, early diagnosis, current treatment modalities and unmet medical needs in the region. Data were collected from a pre-meeting survey questionnaire and responses analysed and presented during the advisory meeting. This review summarizes the evidence discussed at the meeting and provides expert recommendations on the management of HCC. The 2022 update of Barcelona clinic liver cancer (BCLC) staging and treatment strategy and its implementation in the MENA region was extensively discussed. A key consensus of the expert panel was that multidisciplinary care is crucial to effective patient management that results in better clinical outcomes and overall survival of the patient. The panel recommended the use of predictive and early response biomarkers to guide clinicians in arriving at more effective therapeutic decisions. The experts also emphasized the role of robust screening/surveillance systems, population-based registries, effective referral pathways and standardization of guidelines to ensure the successful management of HCC in the region.
ISSN:1478-3223
1478-3231
DOI:10.1111/liv.15685